181 related articles for article (PubMed ID: 36765696)
1. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.
Yan Y; Gauthier MA; Malik A; Fotiadou I; Ostrovski M; Dervovic D; Ghadban L; Tsai R; Gish G; Loganathan SK; Schramek D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765696
[TBL] [Abstract][Full Text] [Related]
2. Receptor-interacting protein kinase 4 and interferon regulatory factor 6 function as a signaling axis to regulate keratinocyte differentiation.
Kwa MQ; Huynh J; Aw J; Zhang L; Nguyen T; Reynolds EC; Sweet MJ; Hamilton JA; Scholz GM
J Biol Chem; 2014 Nov; 289(45):31077-87. PubMed ID: 25246526
[TBL] [Abstract][Full Text] [Related]
3. RIPK4 activates an IRF6-mediated proinflammatory cytokine response in keratinocytes.
Kwa MQ; Scholz GM; Reynolds EC
Cytokine; 2016 Jul; 83():19-26. PubMed ID: 27014863
[TBL] [Abstract][Full Text] [Related]
4. A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.
De Groote P; Tran HT; Fransen M; Tanghe G; Urwyler C; De Craene B; Leurs K; Gilbert B; Van Imschoot G; De Rycke R; Guérin CJ; Holland P; Berx G; Vandenabeele P; Lippens S; Vleminckx K; Declercq W
Cell Death Differ; 2015 Jun; 22(6):1012-24. PubMed ID: 25430793
[TBL] [Abstract][Full Text] [Related]
5. A novel regulatory relationship between RIPK4 and ELF3 in keratinocytes.
Scholz GM; Sulaiman NS; Al Baiiaty S; Kwa MQ; Reynolds EC
Cell Signal; 2016 Dec; 28(12):1916-1922. PubMed ID: 27667567
[TBL] [Abstract][Full Text] [Related]
6. The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function.
Oberbeck N; Pham VC; Webster JD; Reja R; Huang CS; Zhang Y; Roose-Girma M; Warming S; Li Q; Birnberg A; Wong W; Sandoval W; Kőműves LG; Yu K; Dugger DL; Maltzman A; Newton K; Dixit VM
Nature; 2019 Oct; 574(7777):249-253. PubMed ID: 31578523
[TBL] [Abstract][Full Text] [Related]
7. RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis.
Fortugno P; Monetta R; Belli M; Botti E; Angelucci F; Palmerini MG; Nottola SA; De Luca C; Ceccarini M; Salvatore M; Bianchi L; Macioce P; Teson M; Ricci F; ; Macchiarelli G; Didona B; Costanzo A; Castiglia D; Brancati F
Hum Mol Genet; 2022 Aug; 31(15):2535-2547. PubMed ID: 35220430
[TBL] [Abstract][Full Text] [Related]
8. [The role of RIPK4 in epidermis physiology].
Wolnicka-Głubisz A; Madej E; Lisek A
Postepy Biochem; 2021 Mar; 67(1):64-71. PubMed ID: 34378900
[TBL] [Abstract][Full Text] [Related]
9. Disease-associated mutations in IRF6 and RIPK4 dysregulate their signalling functions.
Kwa MQ; Huynh J; Reynolds EC; Hamilton JA; Scholz GM
Cell Signal; 2015 Jul; 27(7):1509-16. PubMed ID: 25784454
[TBL] [Abstract][Full Text] [Related]
10. Depletion of RIPK4 parallels higher malignancy potential in cutaneous squamous cell carcinoma.
Xu J; Wu D; Zhang B; Pan C; Guo Y; Wei Q
PeerJ; 2022; 10():e12932. PubMed ID: 35186499
[TBL] [Abstract][Full Text] [Related]
11. IRF6 expression in basal epithelium partially rescues Irf6 knockout mice.
Kousa YA; Moussa D; Schutte BC
Dev Dyn; 2017 Sep; 246(9):670-681. PubMed ID: 28643456
[TBL] [Abstract][Full Text] [Related]
12. RIPK4 suppresses the TGF-β1 signaling pathway in HaCaT cells.
Dinçer T; Boz Er AB; Er İ; Toraman B; Yildiz G; Kalay E
Cell Biol Int; 2020 Mar; 44(3):848-860. PubMed ID: 31825120
[TBL] [Abstract][Full Text] [Related]
13. Interferon Regulatory Factor 6 Promotes Keratinocyte Differentiation in Response to Porphyromonas gingivalis.
Huynh J; Scholz GM; Aw J; Reynolds EC
Infect Immun; 2017 May; 85(5):. PubMed ID: 28289145
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines.
Xu L; Bajorski P; Poligone B
PLoS One; 2024; 19(4):e0287444. PubMed ID: 38630705
[TBL] [Abstract][Full Text] [Related]
15. Insight Into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis.
Xu J; Wei Q; He Z
Front Oncol; 2020; 10():1562. PubMed ID: 32923402
[TBL] [Abstract][Full Text] [Related]
16. Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.
Botti E; Spallone G; Moretti F; Marinari B; Pinetti V; Galanti S; De Meo PD; De Nicola F; Ganci F; Castrignanò T; Pesole G; Chimenti S; Guerrini L; Fanciulli M; Blandino G; Karin M; Costanzo A
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13710-5. PubMed ID: 21807998
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.
Urwyler-Rösselet C; Tanghe G; Leurs K; Gilbert B; De Rycke R; De Bruyne M; Lippens S; Bartunkova S; De Groote P; Niessen C; Haftek M; Vandenabeele P; Declercq W
J Invest Dermatol; 2018 Jun; 138(6):1268-1278. PubMed ID: 29317263
[TBL] [Abstract][Full Text] [Related]
18. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.
Heim D; Cornils K; Schulze K; Fehse B; Lohse AW; Brümmendorf TH; Wege H
Oncogene; 2015 Jan; 34(3):364-72. PubMed ID: 24413083
[TBL] [Abstract][Full Text] [Related]
19. RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3.
Li H; Luo D; Huttad L; Zhang M; Wang Y; Feng J; Ding Y; Han B
Front Mol Biosci; 2021; 8():654766. PubMed ID: 34222329
[TBL] [Abstract][Full Text] [Related]
20. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
